Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2018

01-10-2018 | Correction

Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

Authors: M. Martín, J. C. de la Torre-Montero, S. López-Tarruella, K. Pinilla, A. Casado, S. Fernandez, Y. Jerez, J. Puente, I. Palomero, R. González del Val, M. del Monte-Millan, T. Massarrah, C. Vila, B. García-Paredes, J. A. García-Sáenz, A. Lluch

Published in: Breast Cancer Research and Treatment | Issue 3/2018

Login to get access

Excerpt

In the original publication of the article, Table 1 was published with incorrect caption and values. The Table 1 with corrected caption and values is given in this Correction. …
Metadata
Title
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
Authors
M. Martín
J. C. de la Torre-Montero
S. López-Tarruella
K. Pinilla
A. Casado
S. Fernandez
Y. Jerez
J. Puente
I. Palomero
R. González del Val
M. del Monte-Millan
T. Massarrah
C. Vila
B. García-Paredes
J. A. García-Sáenz
A. Lluch
Publication date
01-10-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4883-y

Other articles of this Issue 3/2018

Breast Cancer Research and Treatment 3/2018 Go to the issue

Review

Breast cancer and its impact in male transsexuals

Review

Dietary supplements and fatigue in patients with breast cancer: a systematic review

Clinical trial

Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy

Preclinical study

Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer

Review

Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence

Clinical trial

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits